HK1119938A1 - Pharmaceutical composition containing chenopodium ambrosioides extract and its preparation process and application - Google Patents
Pharmaceutical composition containing chenopodium ambrosioides extract and its preparation process and applicationInfo
- Publication number
- HK1119938A1 HK1119938A1 HK08111964.1A HK08111964A HK1119938A1 HK 1119938 A1 HK1119938 A1 HK 1119938A1 HK 08111964 A HK08111964 A HK 08111964A HK 1119938 A1 HK1119938 A1 HK 1119938A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- chenopodium ambrosioides
- application
- pharmaceutical composition
- composition containing
- preparation process
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2005101353590A CN1990007B (zh) | 2005-12-31 | 2005-12-31 | 一种治疗胃病的组合物、制备方法及其用途 |
CN2005101353586A CN1990006B (zh) | 2005-12-31 | 2005-12-31 | 一种土荆芥提取物、其制剂、制备方法与用途 |
CN2006101365003A CN101172132B (zh) | 2006-10-30 | 2006-10-30 | 一种治疗胃病的自乳化制剂及其制备方法 |
PCT/CN2006/003691 WO2007076699A1 (fr) | 2005-12-31 | 2006-12-29 | Composition pharmaceutique contenant un extrait de chenopodium ambrosioides et son procédé de préparation et son application |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1119938A1 true HK1119938A1 (en) | 2009-03-20 |
Family
ID=38227910
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK08111964.1A HK1119938A1 (en) | 2005-12-31 | 2008-10-30 | Pharmaceutical composition containing chenopodium ambrosioides extract and its preparation process and application |
Country Status (7)
Country | Link |
---|---|
US (2) | US8361515B2 (fr) |
EP (1) | EP1982705B8 (fr) |
JP (1) | JP5844954B2 (fr) |
KR (1) | KR101164516B1 (fr) |
HK (1) | HK1119938A1 (fr) |
MY (1) | MY148473A (fr) |
WO (1) | WO2007076699A1 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101164516B1 (ko) | 2005-12-31 | 2012-07-13 | 태슬리 파마슈티컬 그룹 컴퍼니 리미티드 | 양명아주 추출물을 함유하는 약학 조성물, 및 이의 제조방법 및 용도 |
US20100316738A1 (en) * | 2009-06-12 | 2010-12-16 | Desmond JIMENEZ | Methods of inhibiting, preventing, killing and/or repelling insects using simulated blends of chenopodium extracts |
JP2012077033A (ja) * | 2010-10-01 | 2012-04-19 | Kinki Univ | ヘリコバクターピロリの運動能阻害剤 |
WO2012104569A1 (fr) | 2011-02-02 | 2012-08-09 | GILHOLM, Stephen, Philip | Composition de monoterpenoïdes pour le traitement de cancer |
US9107420B2 (en) | 2014-01-13 | 2015-08-18 | Eliana Ellern | Animal shampoo |
CN104474350A (zh) * | 2014-12-20 | 2015-04-01 | 济南伟传信息技术有限公司 | 一种治疗胃溃疡的茶 |
WO2017149392A1 (fr) * | 2016-03-04 | 2017-09-08 | Sharon Anavi-Goffer | Compositions auto-émulsifiantes de modulateurs du récepteur cb2 |
JP2021035912A (ja) | 2017-12-20 | 2021-03-04 | 石原産業株式会社 | 有害生物防除用組成物及び有害生物の防除方法 |
CN110133140B (zh) * | 2019-05-23 | 2022-07-12 | 吉林化工学院 | 一种白鲜地上部分挥发油成分鉴定及其抑菌活性研究 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5039699A (en) * | 1989-03-27 | 1991-08-13 | Lederle (Japan), Ltd. | Anti-peptic ulcer agent |
US5696169A (en) * | 1992-03-13 | 1997-12-09 | Otsuka Pharmaceutical Co., Ltd. | Antibacterial and antifungal activity method, therapeutic method of infectious diseases and preserving method of cosmetics |
CN1052646C (zh) * | 1995-03-23 | 2000-05-24 | 张涌川 | 一种治疗胃脘痛的胶丸及其制备方法 |
AU1881600A (en) * | 1998-12-23 | 2000-07-31 | Alza Corporation | Dosage forms comprising porous particles |
US20030091657A1 (en) * | 2000-03-17 | 2003-05-15 | Helene Chiasson | Plant acaricidal compositions and method using same |
TNSN03139A1 (fr) * | 2001-06-21 | 2005-12-23 | Pfizer Prod Inc | Formulations auto-emulsionnables d'inhibiteurs de la proteine de transfert d'ester de cholesteryle |
JP4081312B2 (ja) * | 2002-06-28 | 2008-04-23 | 佐藤製薬株式会社 | 外用抗真菌剤 |
CN1506118A (zh) * | 2002-12-06 | 2004-06-23 | 苏少宁 | 一种用于消化道检查窥视设备的消毒液 |
CN101172132B (zh) | 2006-10-30 | 2011-10-05 | 天津天士力制药股份有限公司 | 一种治疗胃病的自乳化制剂及其制备方法 |
RU2423111C2 (ru) | 2005-12-31 | 2011-07-10 | Тяньцзинь Тасли Фармасьютикл Ко., Лтд. | ЭКСТРАКТЫ ПРИМЕНЯЕМОГО В КИТАЙСКОЙ МЕДИЦИНЕ РАСТЕНИЯ Chenopodium ambrosioides L., КОМПОЗИЦИИ, ВКЛЮЧАЮЩИЕ УПОМЯНУТЫЕ ЭКСТРАКТЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЕ |
KR101164516B1 (ko) | 2005-12-31 | 2012-07-13 | 태슬리 파마슈티컬 그룹 컴퍼니 리미티드 | 양명아주 추출물을 함유하는 약학 조성물, 및 이의 제조방법 및 용도 |
CN1990006B (zh) | 2005-12-31 | 2011-10-05 | 天津天士力制药股份有限公司 | 一种土荆芥提取物、其制剂、制备方法与用途 |
-
2006
- 2006-12-29 KR KR1020087018649A patent/KR101164516B1/ko active IP Right Grant
- 2006-12-29 US US12/159,609 patent/US8361515B2/en active Active
- 2006-12-29 JP JP2008547835A patent/JP5844954B2/ja active Active
- 2006-12-29 WO PCT/CN2006/003691 patent/WO2007076699A1/fr active Application Filing
- 2006-12-29 MY MYPI20082118A patent/MY148473A/en unknown
- 2006-12-29 EP EP06840721A patent/EP1982705B8/fr not_active Expired - Fee Related
-
2008
- 2008-10-30 HK HK08111964.1A patent/HK1119938A1/xx unknown
-
2012
- 2012-12-21 US US13/725,265 patent/US8586108B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
MY148473A (en) | 2013-04-30 |
KR20090019760A (ko) | 2009-02-25 |
JP5844954B2 (ja) | 2016-01-20 |
KR101164516B1 (ko) | 2012-07-13 |
EP1982705A1 (fr) | 2008-10-22 |
US8586108B2 (en) | 2013-11-19 |
EP1982705B8 (fr) | 2012-08-22 |
US8361515B2 (en) | 2013-01-29 |
JP2009522208A (ja) | 2009-06-11 |
US20090130203A1 (en) | 2009-05-21 |
US20130178516A1 (en) | 2013-07-11 |
WO2007076699A1 (fr) | 2007-07-12 |
EP1982705B1 (fr) | 2012-07-18 |
EP1982705A8 (fr) | 2008-12-10 |
EP1982705A4 (fr) | 2009-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1119938A1 (en) | Pharmaceutical composition containing chenopodium ambrosioides extract and its preparation process and application | |
Fattahi et al. | Total phenolic and flavonoid contents of aqueous extract of stinging nettle and in vitro antiproliferative effect on hela and BT-474 Cell lines | |
KR102078204B1 (ko) | 관절 건강을 위한 조성물 및 방법 | |
Ghareeb et al. | In vitro screening for anti-acetylcholiesterase, anti-oxidant, anti-glucosidase, anti-inflammatory and anti-bacterial effect of three traditional medicinal plants | |
JP2018138598A (ja) | 骨障害、軟骨障害又はその両方の管理又は改善用組成物及び方法 | |
EA201590458A8 (ru) | Способ получения экстракта, извлекаемого из сахарного тростника, и экстракт | |
Zendehbad et al. | Flavonoids and phenolic content in wheat grass plant (Triticum aestivum) | |
Bodhankar et al. | Formulation and in vitro evaluation of dental gel containing ethanglic extract of Mimosa pudica | |
Malm et al. | Anti-Helicobacter pylori activity in vitro of chamomile flowers, coneflower herbs, peppermint leaves and thyme herbs–a preliminary report | |
DE50210906D1 (de) | Arzneimittel enthaltend deuterium zur behandlung der zuckerkrankheit | |
Pavel et al. | Phytochemical and pharmacological research on some extracts obtained from Serpylli herba | |
Surana et al. | Phytochemical analysis and antidepressant activity of Ixora coccinea extracts in experimental models of depression in mice | |
Hamidpour et al. | Chemistry, pharmacology and medicinal property of Russian olive (Elaeagnus angustifolia L.) | |
Bozorgi et al. | Antioxidant activity of Lallemantia royleana (Benth.) seed extract | |
Mykhailenko et al. | The comparative analysis of carboxylic acid composition of four Iris species from Ukraine | |
Chemsa et al. | Antibiofilm formation, antioxidant and anticholinesterase activities of essential oil and methanol extract of Marrubium deserti de Noé | |
Victório et al. | Vasodilator activity of extracts of field Alpinia purpurata (Vieill) K: Schum and A. zerumbet (Pers.) Burtt et Smith cultured in vitro | |
Antonio et al. | Biological properties and antioxidant activity of hawthorn Crataegus mexicana | |
MD3972C2 (ro) | Remediu şi metodă de tratament al stărilor precanceroase | |
Nguyen et al. | In vitro antioxidant, anti-diabetic, anti-cholinesterase, tyrosinase and nitric oxide inhibitory potential of fruiting bodies of Coprinellus micaceus | |
EJIKE-ILIEMENE et al. | Anti-diarrhoea property of crude aqueous leave extract of red apple Psidium guajava in castor oil-induced diarrhoea in rats | |
Calvo et al. | Identification of polyphenols in sea fennel (Crithmum maritimum) and Seaside Arrowgrass (Triglochin maritima) extracts with antioxidant, ACE-I, DPP-IV and PEP-inhibitory capacity | |
NZ702155A (en) | Novel pharmacological use of cimicifuga extract | |
Singh et al. | Bioactivity guided fractionation of ethanol extract of Caesalpinia digyna Rottler roots | |
梅文莉 et al. | Bioactive Constituents from Hydnocarpus hainanensis (Merr.) Sleum. |